|
Volumn 11, Issue 12, 2005, Pages 1293-1294
|
Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHEMOKINE RECEPTOR ANTAGONIST;
CHEMOKINE RECEPTOR CCR5;
CMPD 167;
UNCLASSIFIED DRUG;
ANIMAL MODEL;
ANTIVIRAL ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG MECHANISM;
MACACA;
NONHUMAN;
PRIORITY JOURNAL;
PROVOCATION TEST;
SHIV 162P3;
SIMIAN IMMUNODEFICIENCY VIRUS;
TREATMENT OUTCOME;
VIREMIA;
VIRUS INFECTION;
VIRUS LOAD;
ADMINISTRATION, ORAL;
ANIMALS;
FEMALE;
MACACA;
PYRAZOLES;
RECEPTORS, CCR5;
SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME;
SIMIAN IMMUNODEFICIENCY VIRUS;
TIME FACTORS;
VAGINA;
VALINE;
VIRAL LOAD;
ANIMALIA;
HUMAN IMMUNODEFICIENCY VIRUS 1;
MACACA;
SIMIAN IMMUNODEFICIENCY VIRUS;
SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;
|
EID: 28644432424
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm1321 Document Type: Article |
Times cited : (83)
|
References (14)
|